Bolt M W, Racz W J, Brien J F, Bray T M, Massey T E
Department of Pharmacology and Toxicology, Queen's University, Kingston, ON, Canada.
Can J Physiol Pharmacol. 1998 Jul-Aug;76(7-8):721-7. doi: 10.1139/cjpp-76-7-8-721.
Treatment of cardiac dysrhythmias with the iodinated benzofuran derivative amiodarone (AM) is limited by pulmonary toxicity. The susceptibilities of different lung cell types of male Golden Syrian hamsters to AM-induced cytotoxicity were investigated in vitro. Bronchoalveolar lavage and protease digestion to release cells, followed by centrifugal elutriation and density gradient centrifugation, resulted in preparations enriched with alveolar macrophages (98%), alveolar type II cells (75-85%), and nonciliated bronchiolar epithelial (Clara) cells (35-50%). Alveolar type II cell and Clara cell preparations demonstrated decreased viability (by 0.5% trypan blue dye exclusion) when incubated with 50 microM AM for 36 h, and all AM-treated cell preparations demonstrated decreased viability when incubated with 100 or 200 microM AM. Based on a viability index ((viability of AM-treated cells/viability of controls) x 100%), the Clara cell fraction was significantly (p<0.05) more susceptible than all of the other cell types to 50 microM AM. However, AM cytotoxicity was greatest (p<0.05) in alveolar macrophages following incubation with 100 or 200 microM AM. There was no difference between any of the enriched cell preparations in the amount of drug accumulated following 24 h of incubation with 50 microM AM, whereas alveolar macrophages accumulated the most drug during incubation with 100 microM AM. Thus, the most susceptible cell type was dependent on AM concentration. AM-induced cytotoxicity in specific cell types may initiate processes leading to inflammation and pulmonary fibrosis.
碘化苯并呋喃衍生物胺碘酮(AM)治疗心律失常受到肺部毒性的限制。在体外研究了雄性金黄叙利亚仓鼠不同肺细胞类型对AM诱导的细胞毒性的敏感性。通过支气管肺泡灌洗和蛋白酶消化来释放细胞,随后进行离心淘析和密度梯度离心,得到富含肺泡巨噬细胞(98%)、II型肺泡细胞(75 - 85%)和无纤毛细支气管上皮(克拉拉)细胞(35 - 50%)的细胞制剂。II型肺泡细胞和克拉拉细胞制剂在与50微摩尔/升AM孵育36小时后活力降低(通过台盼蓝染料排斥法降低0.5%),并且所有经AM处理的细胞制剂在与100或200微摩尔/升AM孵育时活力均降低。基于活力指数((经AM处理的细胞活力/对照细胞活力)×100%),克拉拉细胞组分对50微摩尔/升AM的敏感性显著高于所有其他细胞类型(p<0.05)。然而,在与100或200微摩尔/升AM孵育后,肺泡巨噬细胞中的AM细胞毒性最大(p<0.05)。在与50微摩尔/升AM孵育24小时后,任何富集的细胞制剂之间积累的药物量没有差异,而在与100微摩尔/升AM孵育期间,肺泡巨噬细胞积累的药物最多。因此,最敏感的细胞类型取决于AM浓度。特定细胞类型中AM诱导的细胞毒性可能引发导致炎症和肺纤维化的过程。